GENE HAVING EXTRACELLULAR DOMAIN OF BCMA AS LABEL, POLYPEPTIDE, RECOMBINANT EXPRESSION VECTOR, GENETICALLY ENGINEERED CELL AND USE THEREOF
Provided in the present invention are a gene having an extracellular domain of BCMA as a label, a polypeptide, a recombinant expression vector, a genetically engineered cell and the use thereof. The gene tBCMA is a gene encoding all or part of the sequence of the extracellular domain of BCMA, or a g...
Gespeichert in:
Hauptverfasser: | , |
---|---|
Format: | Patent |
Sprache: | chi ; eng ; fre |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Provided in the present invention are a gene having an extracellular domain of BCMA as a label, a polypeptide, a recombinant expression vector, a genetically engineered cell and the use thereof. The gene tBCMA is a gene encoding all or part of the sequence of the extracellular domain of BCMA, or a gene encoding a sequence having at least 85% identity to the all or part of the sequence. According to the present invention, an extracellular domain polypeptide (tBCMA) of a B cell maturation antigen is used as a label, and the gene is used for the techniques of detection and clearance of genetically engineered immune cells. The present invention can be widely used for the detection of a variety of genetically engineered immune cells, effectively solves the problem of the detection of genetically engineered immune cells after preparation and back-transfusion, and provides a feasible strategy for clinical treatment when these cells need to be eliminated due to serious toxic side effects.
La présente invention concer |
---|